dRx Capital
Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Expansion
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, France, Italy, Denmark, Switzerland, Spain, South Korea, Austria, Netherlands, Sweden, Belgium, Norway, Finland
Industries Focus
- Healthcare
- Software
- SaaS
- Artificial Intelligence
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Information Technology
- Machine Learning
- Biotechnology
- Pharmaceutical
- Big Data
- AI
- Clinical Trials
- Analytics
- Data Science
- Health Diagnostics
- Health IT
- Commercialization
- Home Health Care
- Healthcare Data
- R&D Optimization
- Patient Care
- Pharma Supply Chain
Investment Size:
5,000,000 to 100,000,000 USD
Investor Details Founded: 2015
dRx Capital is a corporate venture capital firm established in 2015 as a joint venture between Novartis and Qualcomm Ventures. The firm focuses on early-stage investments in digital health companies, aiming to support entrepreneurs who are transforming healthcare through data and digital technology. Their investment areas include artificial intelligence, machine learning, big data, research and development optimization, patient care, and the pharmaceutical supply chain. dRx Capital typically invests between $5 million and $100 million in innovative technology platforms aimed at improving access to healthcare and enhancing the practice of medicine.
The firm operates primarily in the United States and Switzerland, leveraging the extensive networks of its parent companies in the pharmaceutical, mobile, IT, and investment communities. dRx Capital's team comprises fund managers from both Novartis and Qualcomm, bringing together expertise in life sciences, business, and technology. This collaboration enables the firm to take a hands-on approach to investment, working closely with portfolio companies to deliver real clinical impact.
Since its inception, dRx Capital has made 30 investments, with notable exits including Omada Health, SomaLogic, and Xealth. The firm's portfolio spans various sectors within healthcare and life sciences, reflecting its commitment to advancing digital health solutions that address unmet patient needs across the healthcare spectrum and the world.
Requirements
- Innovative digital health solutions
- Early-stage companies
- Focus on data and digital technology in healthcare
Contact
[Official Website Hidden]
[HQ Location Hidden]
Portfolio Companies
- Omada Health
- Somalogic
- Xealth
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$9.95
-
$14.95
-
$19.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of dRx Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim